Aluminum and neurodegenerative disease: therapeutic implications.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  American Journal of Kidney Diseases

• Publication date

  1985-11-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S0272-6386(85)80088-3PMID 2865894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy

  2004cited by this paper
• Alzheimer's disease in Down's syndrome

  1985cited by this paper
• Desferrioxamine and Alzheimer's dementia.

  1985cited by this paper
• Desferrioxamine and Alzheimer's dementia

  1985cited by this paper
• Microinjection of calmodulin antibodies into cultured chromaffin cells blocks catecholamine release in response to stimulation.

  1985cited by this paper
• Determination of desferoxamine and a major metabolite by high-performance liquid chromatography. Application to the treatment of aluminium-related disorders.

  1985cited by this paper
• Calcium metabolism in aluminum encephalopathy.

  1985cited by this paper
• Degradation of Neurofilament Proteins by Purified Human Brain Cathepsin D

  1984cited by this paper
• Interaction between calmodulin and microtubule‐associated proteins prepared at different stages of brain development

  1984cited by this paper
• Evidence that the major postsynaptic density protein is a component of a Ca2+/calmodulin-dependent protein kinase.

  1984cited by this paper
• Participation of calcium and calmodulin in the formation of acetylcholine receptor clusters

  1984cited by this paper
• Chromosome location of genes controlling aluminum tolerance in wheat, rye, and triticale

  1984cited by this paper
• Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport

  1984cited by this paper
• Molecular aspects of aluminum toxicity

  1984cited by this paper
• Organic acids prevent aluminum-induced conformational changes in calmodulin.

  1984cited by this paper
• Calmodulin-microtubule association in cultured mammalian cells

  1984cited by this paper
• Na+-Ca2+ exchange in the axolemma-rich membrane vesicle preparations from the walking-leg nerves of the American lobster.

  1984cited by this paper
• Intranuclear aluminum accumulation in chronic animals with experimental neurofibrillary changes.

  1984cited by this paper
• The structure and function of the blood-brain barrier.

  1984cited by this paper
• Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam.

  1984cited by this paper
• Calmodulin regulation of the ATP-dependent calcium uptake by inverted vesicles prepared from rabbit synaptosomal plasma membranes.

  1984cited by this paper
• Calcium-dependent calmodulin binding to cholinergic synaptic vesicles.

  1984cited by this paper
• Calmodulin is tightly associated with synaptic vesicles independent of calcium.

  1984cited by this paper
• The calmodulin-binding domain on microtubule-associated protein 2.

  1984cited by this paper
• The structure and function of the blood-brain barrier.

  1984cited by this paper
• Calcium and vitamin D metabolism in guamanian chamorros with amyotrophic lateral sclerosis and parkinsonism–dementia

  1984cited by this paper
• Aluminium Uptake by Roots of Two Winter Wheat Varieties of Different Tolerance to Aluminium

  1983cited by this paper
• Regulation by calcium ions of glutamate receptor binding in hippocampal slices.

  1983cited by this paper
• High affinity uptake of GABA and glycine by rabbits with aluminum-induced neurofibrillary changes

  1983cited by this paper
• Ocular toxicity of high-dose intravenous desferrioxamine.

  1983cited by this paper
• Calmodulin dependent formation of membrane potential in barley root plasma membrane vesicles: A biochemical model of aluminum toxicity in plants

  1983cited by this paper
• Modulation of presynaptic neurotransmission. I: Theories of the mechanism of synaptic vesicle fusion with the presynaptic axonal plasma membrane.

  1983cited by this paper
• Characterization of Brain Synaptic Vesicle Phospholipase A2 Activity and Its Modulation by Calmodulin, Prostaglandin E2, Prostaglandin F2α, Cyclic AMP, and ATP

  1983cited by this paper
• Microinjection of Ca++-calmodulin causes a localized depolymerization of microtubules

  1983cited by this paper
• REGULATION OF THE CYTOSKELETON BY Ca2+‐CALMODULIN AND cAMP *

  1982cited by this paper
• Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam.

  1982cited by this paper
• Effects of Cd2+, Mn2+, and Al3+ on rat brain synaptosomal uptake of noradrenaline and serotonin.

  1982cited by this paper
• Actin-binding proteins—regulators of cell architecture and motility

  1982cited by this paper
• Comparison of calmodulin binding to brain synaptic and coated vesicles.

  1982cited by this paper
• Noncompetitive inhibition by aluminum, scandium and yttrium of acetylcholinesterase from Electrophorus electricus.

  1982cited by this paper
• Sodium channel, sodium pump, and sodium-calcium exchange activities in synaptosomal plasma membrane vesicles.

  1982cited by this paper
• Physiological implications of the presence, distribution, and regulation of calmodulin in eukaryotic cells.

  1982cited by this paper
• Intermediate (10 nm) filament proteins and the Ca2+-activated proteinase specific for vimentin and desmin in the cells from fish to man: an example of evolutionary conservation.

  1982cited by this paper
• Phase separation in lipid bilayers containing integral proteins. Computer simulation studies.

  1982cited by this paper
• The effect of calcium on acetylcholine receptor synthesis

  1981cited by this paper
• Regulation of acetylcholine receptor phosphorylation by calcium and calmodulin.

  1981cited by this paper
• The calmodulin‐binding protein in microtubules is tau factor

  1981cited by this paper
• Selective inhibition of L-glutamate and gammaaminobutyrate transport in nerve ending particles by aluminium, manganese, and cadmium chloride.

  1981cited by this paper
• The effects of cadmium, manganese and aluminium on sodium-potassium-activated and magnesium-activated adenosine triphosphatase activity and choline uptake in rat brain synaptosomes.

  1980cited by this paper
• Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons.

  1980cited by this paper
• Interaction of aluminum species with deoxyribonucleic acid.

  1980cited by this paper
• Intermolecular hydrogen bonding between lipids: influence on organization and function of lipids in membranes.

  1980cited by this paper
• Repressed template activity of chromatin of pea roots treated by aluminium

  1980cited by this paper
• Central cholinergic activity in aluminum‐induced neurofibrillary degeneration

  1980cited by this paper
• Cholinergic enzymes in neurofibrillary degeneration produced by aluminium.

  1980cited by this paper
• Calmodulin.

  1980cited by this paper
• The effect of A13+ on the physical properties of membrane lipids in Thermoplasma acidophilum.

  1978cited by this paper
• The effect of Al3+ on the physical properties of membrane lipids in Thermoplasmaacidophilum

  1978cited by this paper
• Aluminum levels in brain in Alzheimer's disease.

  1978cited by this paper
• Aluminium, neurofibrillary degeneration and Alzheimer's disease.

  1976cited by this paper
• Letter: Quality control of "dextrostix".

  1976cited by this paper
• Studies on Amyotrophic Lateral Sclerosis by Neutron Activation Analysis

  1976cited by this paper
• BROMOCRIPTINE AND SERUM-GROWTHHORMONE LEVELS IN DIABETES MELLITUS

  1975cited by this paper
• Effect of aluminum upon conditioned avoidance response acquisition in the absence of neurofibrillary degeneration.

  1975cited by this paper
• Intracellular aluminum binding; A histochemical study

  1974cited by this paper
• EFFECTS OF ALUMINUM SALTS ON CULTURED NEUROBLASTOMA CELLS

  1974cited by this paper
• Alzheimer's disease in Down's syndrome: visual retention deficits.

  1974cited by this paper
• Brain Aluminum Distribution in Alzheimer's Disease and Experimental Neurofibrillary Degeneration

  1973cited by this paper
• The amyotrophic lateral sclerosis/parkinsonism-dementia complex: a ten-year follow-up on Guam. I. Epidemiologic studies.

  1966cited by this paper
• The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism

  1964cited by this paper
• Hydroxamatkomplexe II. Die Anwendung der pH‐Methode

  1963cited by this paper
• Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features.

  1961cited by this paper
• Parkinsonism-dementia complex, en endemic disease on the island of Guam. Clinical, pathological, genetic and epidemiological features.

  1961cited by this paper
• Early senile dementia in mongoloid idiocy.

  1948cited by this paper

• The removal of elemental aluminium and its ions using some heteroatom-decorated graphitic carbonitride nanosheets: a DFT study

  2024cites this paper
• Multifunctional Molecule, JM-20, Reverses Aluminum Chloride-Induced Memory Impairment and Neuronal Damage in Rats

  2021cites this paper
• JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats.

  2021cites this paper
• Inhibitory effect of aluminium on calcium absorption in small intestine of rats with different thyroid hormone status.

  2009cites this paper
• Effect of aluminium on duodenal calcium transport in pregnant and lactating rats treated with bromocriptine.

  2007cites this paper
• Deferoxamine and aluminum clearance in pediatric hemodialysis patients

  2004cites this paper
• ELECTROCHEMICAL AND SPECTROMETRIC STUDIES ON THE PRINCIPLE OF INDIRECT DETER-MINATION OF ALUMINUM USING l-DOPA AS AN ELECTROACTIVE COMPLEXING LIGAND

  2002cites this paper
• Trace Element Requirements in the Elderly

  2000cites this paper
• The effect of age on aluminum retention in rats.

  1997cites this paper
• Adverse effects of aluminium-chelating compounds for clinical use.

  1996cites this paper
• Reproductive and developmental toxicity of aluminum: a review.

  1995cites this paper
• The Role of Aluminium in Dementia of Alzheimer’s Type: A Review of the Hypotheses and Summary of the Evidence

  1994cites this paper
• The transport of aluminum and water across the rat small intestine.

  1993cites this paper
• Toxicity of aluminium: a historical review, Part 2.

  1993cites this paper
• The effects of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic hemodialysis patients.

  1992cites this paper
• Al-ATP as an intracellular carrier of Al(III) ion.

  1991cites this paper
• A1-ATP as an intracellular carrier of A1(III) ion

  1991cites this paper
• Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole.

  1990cites this paper
• Dementias: the role of magnesium deficiency and an hypothesis concerning the pathogenesis of Alzheimer's disease.

  1990cites this paper
• Suppression of deferoxamine mesylate treatment — induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation

  1990cites this paper
• Nutrition and dementia.

  1989cites this paper
• Aluminum: a pediatric overview.

  1988cites this paper
• Kinetics and mechanism of aluminum(III)/siderophore ligand exchange: mono(deferriferrioxamine B)aluminum(III) formation and dissociation in aqueous acid solution

  1987cites this paper
• Total and poly(A) RNA yields during an aluminum encephalopathy in rabbit brains

  1986cites this paper
• Aluminum: a role in degenerative brain disease associated with neurofibrillary degeneration.

  1986cites this paper